Hedgehog Pathway Activation in Chronic Myelogenous Leukemia
Author Information
Author(s): Long Bing, Zhu Huanling, Zhu Cuixia, Liu Ting, Meng Wentong
Primary Institution: West China Hospital, Sichuan University
Hypothesis
The study aims to determine the expression of Hedgehog signaling molecules in Chronic Myelogenous Leukemia (CML) patients and normal individuals.
Conclusion
Activation of the Hedgehog pathway may be associated with the progression of CML, and imatinib treatment does not significantly influence this pathway in CML-CP patients.
Supporting Evidence
- Sonic hedgehog, Smoothened, and Gli1 genes were significantly upregulated in CML patients compared to normal individuals.
- The levels of Shh and Smo mRNA in chronic phase CML patients were lower than in blast crisis patients.
- No significant differences were found in Hedgehog signaling expression between imatinib-treated and untreated CML-CP patients.
Takeaway
This study found that a specific pathway in cells, called the Hedgehog pathway, is more active in patients with a type of blood cancer called CML, and a common treatment doesn't seem to affect it.
Methodology
The study used semiquantitative PCR to analyze the expression of Hedgehog signaling molecules in CML patients and compared it with healthy controls.
Limitations
The study did not separate primary CD34+ leukemic cells, which may affect the results.
Participant Demographics
{"male":43,"female":17,"CML_phase":{"chronic_phase":38,"accelerated_phase":9,"blast_crisis":13},"treatment":{"with_imatinib":31,"without_imatinib":7}}
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website